2-Aminophenoxazine-3-one and 2-amino-4,4α-dihydro-4,7-dimethyl-3H-phenoxazine-3-one cause cellular apoptosis by reducing higher intracellular pH in cancer cells

Proceedings of the Japan Academy Series B: Physical and Biological Sciences

Volumn 87, Issue 4, 2011, Pages 199-213

  Che, Xiao Fang ^a   Zheng, Chun Lei ^b   Akiyama, Shin Ichi ^c   Tomoda, Akio ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b FUDAN UNIVERSITY   (China)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Apoptosis; Cancer cells; Intracellular pH; Phenoxazines

Indexed keywords

2 AMINO 4,4ALPHA DIHYDRO 4ALPHA,7 DIMETHYL 3H PHENOXAZINE 3 ONE; 2-AMINO-4,4ALPHA-DIHYDRO-4ALPHA,7-DIMETHYL-3H-PHENOXAZINE-3-ONE; OXAZINE DERIVATIVE;

APOPTOSIS; ARTICLE; BIOLOGICAL MODEL; CHEMISTRY; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; INTRACELLULAR SPACE; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; NEOPLASM; PATHOLOGY; PH; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; ENDOTHELIAL CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; INTRACELLULAR SPACE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MODELS, BIOLOGICAL; NEOPLASMS; OXAZINES;

EID: 81455156197     PISSN: 03862208     EISSN: 13492896     Source Type: Journal    
DOI: 10.2183/pjab.87.199     Document Type: Article

References (62)

1. Warburg, O. (1956) On the origin of cancer cells. Science 24, 309-314.
2. Hsu, P.P. and Sabatini, D.M. (2008) Cancer cell metabolism: Warburg and beyond. Cell 134, 703-707.
3. Zhon, D., Xiong, L., Liu, T., Liu, X., Liu, X., Chen, J., Sun, S.-Y., Khuri, F.R., Zong, Y., Zhou, Q. and Zhou, W. (2009) The glycolytic inhibitor 2-deoxyglucose activates multiple prosurvival pathways through IGFlR. J. Biol. Chem. 284, 23225-23233.
4. Shara, I.B., Tanti, J.-F. and Bust, F. (2010) The combination of metformin and 2-deoxyglucose inhibits autophagy and induces AMPK-dependent apoptosis in prostate cancer cells. Autophagy 6, 670-671.
5. Izumi, H., Torigoe, T., Ishiguchi, H., Uramoto, H., Yoshida, Y., Tanabe, M., Ise, T., Murakami, T., Yoshida, T., Nomoto, M. and Kohno, K. (2003) Cellular pH regulators: potentially promising molecular target for cancer chemotherapy. Cancer Treat. Rev. 29, 541-549.
6. Vaupel, P., Kallinowski, F. and Okunieff, P. (1989) Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 49, 6449-6465.
7. Duhm, J. (1971) Effects of 2,3-diphosphoglycerate and other organic phosphate compounds on oxygen affinity and intracellular pH of human erythrocytes. Pflugers Arch. 326, 341-356.
8. Minakami, S., Tomoda, A. and Tsuda, S. (1975) Effect of intracellular pH (pHi) change on red cell glycolysis. In Erythrocyte Structure and Function (ed. Brewers, G.). Alan R. Liss Inc., New York, pp. 149-162.
9. Yamagata, M. and Tannock, I.F. (1996) The chronic administration of drugs that inhibit the regulation of intracellular pH: in vitro and anti-tumor effects. Br. J. Cancer 73, 1328-1334.
10. Wahl, M.L., Owen, J.A., Burd, R., Herlands, R.A., Nogami, S.S., Rodeck, U., Berd, D., Leeper, D.B. and Owen, C.S. (2002) Regulation of intracellular pH in human melanoma: potential therapeutic implications. Mol. Cancer Ther. 1, 617-628.
11. Tse, C.M., Levine, S.A., Yun, C.H.C., Nath, S., Pouyssegur, J. and Donowitz, M. (1994) Molecular properties, kinetics and regulation of mammalian NaD/HD exchangers. Cell. Physiol. Biochem. 4, 2282-2300.
12. Putney, L.K., Denker, S.P. and Barber, B.L. (2002) The changing face of the NaD/HD exchanger, NHE1: structure, regulation, and cellular actions. Annu. Rev. Pharmacol. Toxicol. 42, 527-552.
13. Shrode, L.D., Tapper, H. and Grinstein, S. (1997) Role of intracellular pH in proliferation, transformation and apoptosis. J. Bioenerg. Biomembr. 29, 393-399.
14. Litman, T., Pedersen, S.F., Karamhoft, B., Skovsgaad, T. and Hoffmann, E.K. (1998) pH regulation in sensitive multidrug resistant Ehrlich ascites tumor cells. Cell. Physiol. Biochem. 8, 137-150.
15. Goossens, J.F., Henichrt, J.P., Dassonneville, L., Facompre, M. and Bailly, C. (2000) Relation between intracellular acidification and camptothecin-induced apoptosis in leukemia cells. Eur. J. Pharm. Sci. 10, 125-131.
16. Barry, M.A., Reynolds, J.E. and Eastman, A. (1993) Etoposide-induced apoptosis in human HL-60 cells is associated with intracellular acidification. Cancer Res. 53, 2349-2357.
17. Che, X.F., Akiyama, S. and Tomoda, A. (2008) Suppression of the proliferation of cancer cell lines, KB-3-1 and K562 cells preceded by a decrease in intracellular pH caused by phenoxazine derivatives. Oncol. Rep. 19, 1253-1258.
18. Pérez-Sala, D., Collado-Escobar, D. and Mollinedo, F. (1995) Intracellular alkalinization suppresses lovastatin-induced apoptosis in HL-60 cells through the inactivation of a pH-dependent endonuclease. J. Biol. Chem. 270, 6235-6242.
19. Gillies, R.J. (1981) Intracellular pH and growth control in eukaryotic cells. In The Transformed Cell (ed. Cameron, I.L.). Academic Press, New York, pp. 348-382.
20. Shimizu, S., Suzuki, M., Tomoda, A., Arai, S., Taguchi, H., Hanawa, T. and Kamiya, S. (2004) Phenoxazine compounds produced by the reactions with bovine hemoglobin show antimicrobial activity against non-tuberculosis mycobacteria. Tohoku J. Exp. Med. 203, 47-52.
21. Tomoda, A., Arai, S., Ishida, R., Shimamoto, T. and Ohyashiki, K. (2001) An improved method for the rapid preparation of 2-amino-4,4,-dihydro-4,7-dimethyl-3H-phenoxazine-3-one, a novel antitumor agent. Bioorg. Med. Chem. Lett. 11, 1057-1058.
22. Shimamoto, T., Tomoda, A., Ishida, R. and Ohyashiki, K. (2001) Antitumor effects of a novel phenoxazine derivative on human leukemia cell lines in vitro and in vivo. Clin. Cancer Res. 704, 704-708.
23. Koshibu-Koizumi, J., Akazawa, M., Iwamoto, T., Takasaki, M., Mizuno, F., Kobayashi, R., Abe, A., Tomoda, A., Hamatake, M. and Ishida, R. (2002) Antitumor activity of a phenoxazine compound, 2-amino-4,4,-dihydro-4,7-dimethyl-3H-phenoxazine-3-one against human B cell and T cell lymphoblastoid cell lines: induction of mixed types of cell death, apoptosis and necrosis. J. Cancer Res. Clin. Oncol. 128, 363-368.
24. Miyano-Kurosaki, N., Kurosaki, K., Hayashi, M., Takaku, H., Hayafune, M., Shirato, K., Kasuga, T., Endo, T. and Tomoda, A. (2006) 2-Aminophenoxazine-3-one suppresses the growth of mouse malignant melanoma B16 cells transplanted into C57BL/6Cr Slc mice. Biol. Pharm. Bull. 29, 2197-2201.
25. Shirato, K., Imaizumi, K., Abe, A. and Tomoda, A. (2007) Phenoxazine derivatives induce caspaseindependent cell death in human glioblastoma cell lines, A-172 and U-231 MG. Oncol. Rep. 17, 201-208.
26. Miyano-Kurosaki, N., Ikegami, K., Kurosaki, K., Endo, T., Aoyagi, H., Hanami, M., Yasumoto, J. and Tomoda, A. (2009) Anticancer effects of phenoxazine derivatives revealed by inhibition of cell growth and viability, disregulation of cell cycle, and apoptosis induction in HTLV-1-positive leukemia cells. J. Pharmacol. Sci. 110, 87-97.
27. Zheng, C.L., Che, X.F., Akiyama, S., Miyazawa, K. and Tomoda, A. (2010) 2-Aminophenoxazine-3-one induces cellular apoptosis by causing rapid intracellular acidification and generating reactive oxygen species in human lung adenocarcinoma cells. Int. J. Oncol. 36, 641-650.
28. Rich, I.N., Worthington-White, D., Garden, O.A. and Musk, P. (2000) Apoptosis of leukemic cells accompanies reduction in intracellular pH after targeted inhibition of the NaD/HD exchanger. Blood 95, 1427-1434.
29. Tomoda, A., Tsuda-Hirota, S. and Minakami, S. (1977) Glycolysis of red cell suspended in solutions of impermeable solutes: Intracellular pH and glycolysis. J. Biochem. 81, 697-701.
30. Ward, H.W.C. (1973) Actinomycin D for Wilms's tumor. Br. Med. J. 2, 661.
31. Motohashi, N., Mitscher, L.A. and Meyer, R. (1991) Potential antitumor phenoxazines. Med. Res. Rev. 11, 239-294.
32. Nakachi, T., Tabuchi, T., Takasaki, A., Arai, S., Miyazawa, K. and Tomoda, A. (2010) Anticancer activity of phenoxazines produced by bovine erythrocytes on colon cancer cells. Oncol. Rep. 23, 1517-1522.
33. Nagata, H., Che, X.-F., Miyazawa, K., Tomoda, A., Konishi, M., Ubukata, H. and Tabuchi, T. (2011) Rapid decrease of intracellular pH associated with inhibition of NaD/HD exchanger precedes apoptotic events in the MNK and MNK74 gastric cancer cell lines treated with 2-aminophenoxazine-3-one. Oncol. Rep. 25, 341-346.
34. Anzai, K., Isono, K., Okuma, K. and Suzuki, S. (1959) The new antibiotics, questiomycins A and B. J. Antibiotics Ser. A 13, 125-132.
35. Hanawa, T., Osaki, T., Manzoku, T., Fukuda, M., Kawakami, H., Tomoda, A. and Kamiya, S. (2010) In vitro antibacterial activity of Phx-3 against Helicobacter pylori. Biol. Pharm. Bull. 33, 188-191.
36. Fukuda, G., Yoshitake, N., Khan, Z.A., Kanazawa, M., Notoya, Y., Che, X.-F., Akiyama, S., Tomoda, A., Chakrabarti, S. and Odawara, M. (2005) 2-Aminophenoxazine-3-one attenuates glucose-induced augmentation of embryonic form of myosin heavy chain, endothelin-1 and plasminogen activator inhibitor-1 in human umbilical vein endothelial cells. Biol. Pharm. Bull. 28, 797-801.
37. Kohno, K., Miyake, M., Sano, O., Tanaka-Kataoka, M., Yamamoto, S., Koya-Miyata, S., Arai, N., Fujii, M., Watanabe, H., Ushio, S., Iwaki, K. and Fukuda, S. (2008) Anti-inflammatory and immunomodulatory properties of 2-amino-3H-phenoxazin-3-one. Biol. Pharm. Bull. 31, 1938-1945.
38. Iwata, A., Yamaguchi, T., Sato, K., Yoshitake, N. and Tomoda, A. (2005) Suppression of proliferation of poliovirus and porcine parvovirus by novel phenoxazines, 2-amino-4,4,-dihydro-4,7-dimethyl-3H-phenoxazine-3-one and 3-amino-1,4,-dihydro-4,8-dimethyl-2H-phenoxazine-2-one. Biol. Pharm. Bull. 28, 9905-9907.
39. Uruma, T., Yamaguchi, H., Fukuda, M., Kawakami, H., Goto, H., Kishimoto, T., Yamamoto, Y., Tomoda, A. and Kamiya, S. (2005) Clamydia pneumoniae growth inhibition in human monocytic THP-1 cells and human epithelial HEp-2 cells by a novel phenoxazine derivative. J. Med. Microbiol. 54, 1143-1149.
40. Hara, K., Okamoto, M., Aki, T., Yagita, H., Tanaka, H., Mizukami, Y., Nakamura, H., Tomoda, A., Hamasaki, N. and Kang, D. (2005) Synergistic enhancement of TRAIL- and tumor necrosis factor,-induced cell death by a phenoxazine derivative. Mol. Cancer Ther. 4, 11121-11127.
41. Minakami, S. and Yoshikawa, H. (1966) The effect of active cation transport, pH and inorganic phosphate concentration on erythrocyte glycolysis. J. Biochem. 59, 145-150.
42. Kim, K.M. and Lee, Y.J. (2005) Role of HER-2/neu signaling in sensitivity to tumor necrosis factorrelated apoptosis-inducing ligand: Enhancement of TRAIL-mediated apoptosis by amiloride. J. Cell. Biochem. 96, 376-389.
43. Wenner, C. (1975) Regulation of energy metabolism in normal and tumor tissues. In Cancer: A Comprehensive Treatise (ed. Becker, F.F.). Plenum, New York, pp. 389-403.
44. Ui, M. (1966) A role of phosphofructokinase in pH dependent regulation of glycolysis. Biochim. Biophys. Acta 124, 310-322.
45. Maidorn, R.P., Cragoe, E.J. and Tannock, I.F. (1993) Therapeutic intracellular pH as a possible mechanism of tumor selective therapy. Br. J. Cancer 67, 297-303.
46. Reshkin, S.J., Bellizi, A., Cardone, R.A., Tommashino, M., Casavola, V. and Paradiso, A. (2003) Paclitaxel induces apoptosis via protein kinase A- and p38 mitogen-activated proteindependent inhibition of the NaD/HD exchanger (NHE) NHE isoform 1 in human breast cancer cells. Clin. Cancer Res. 9, 2366-2373.
47. Matsuyama, S. and Reed, J.C. (2000) Mitochondriadependent apoptosis and cellular pH regulation. Cell Death Differ. 7, 1155-1165.
48. Matsuyama, S., Liopis, J., Deveraux, Q.L., Tsien, R.Y. and Reed, J.C. (2000) Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis. Nat. Cell Biol. 2, 318-325.
49. Lagadic-Gossmann, D., Hue, L. and Lecureur, V. (2004) Alterations of intracellular pH homeostasis in apoptosis: origins and roles. Cell Death Differ. 11, 953-961.
50. Shirato, K., Imaizumi, K., Miyazawa, K., Takasaki, A., Mizuguchi, J., Che, X.-F., Akiyama, S. and Tomoda, A. (2008) Apoptosis induction preceded by mitochondrial depolarization in multiple myeloma cell line U266 by 2-aminophenoxazine-3-one. Biol. Pharm. Bull. 31, 62-67.
51. Takasaki, A., Hanyu, H., Iwamoto, T., Shirato, K., Izumi, R., Toyota, H., Mizuguchi, J., Miyazawa, K. and Tomoda, A. (2009) Mitochondrial depolarization and apoptosis associated with sustained activation of c-jun-N-terminal kinase in the human multiple myeloma cell line U266 induced by 2-aminophenoxazine-3-one. Mol. Med. Report. 2, 199-203.
52. Kennedy, S.G., Wagner, A.J., Conzen, S.D., Jordan, J., Bellacusa, A., Tsichlis, P.N. and Hay, N. (1997) The PI3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev. 11, 7701-7713.
53. Brunet, A., Bonni, A., Zigmond, M.J., Lin, M.Z., Juo, P., Hu, L.S., Anderson, M.J., Arden, K.C., Blenis, J. and Greenberg, M.E. (1999) Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 96, 857-868.
54. Enoki, E., Sada, K., Qu, X., Kyo, S., Miah, S.M.S., Hanani, T., Tomoda, A. and Yamamura, H. (2004) The phenoxazine derivative Phx-1 suppresses IgEmediated degranulation in rat basophilic leukemia RBL-2H3 cells. J. Pharmacol. Sci. 94, 329-333.
55. Thimmaiah, K.N., Easton, J.B., Germain, G.S., Morton, C.L., Kamath, S., Buolamwinini, J.K. and Houghton, P.J. (2005) Identification of N10-substituted phenoxazines as potten and specific inhibitors of Akt signaling. J. Biol. Chem. 280, 31924-31935.
56. Hendrich, A.B., Stanczak, K., Komorowska, M., Motohashi, N., Kawase, M. and Michalak, K. (2006) A study on the perturbation of model lipid membranes by phenoxazines. Bioorg. Med. Chem. 14, 5948-5954.
57. Watanabe, T., Ono, M., Hirayama, T. and Fukui, S. (1987) 2,7-Diamino-3,8-dimethylphenazine as the major mutagenic product from the reaction of 2,4-diaminotoluene with hydrogen peroxide. Mutat. Res. 190, 113-117.
58. Tomoda, A., Shirasawa, E., Nagano, S., Minami, M. and Yoneyama, Y. (1984) Involvement of oxidoreactive reactions of intracellular haemoglobin in the metabolism of 3-hydroxyanthranilic acid in human erythrocytes. Biochem. J. 222, 755-760.
59. Dykens, J., Sullivan, S.G. and Stern, A. (1987) Oxidative reactivity of the tryptophan metabolites 3-hydroxyanthranilate, cinnabarinate, quinolinate and picolinate. Biochem. Pharmacol. 36, 211-217.
60. Hollstein, U. (1974) Actinomycin. Chemistry and mechanism of action. Chem. Rev. 74, 625-652.
61. Mori, H., Honda, K., Ishida, R., Nohira, T. and Tomoda, A. (2000) Antitumor activity of 2-amino-4,4,-dihydro-4,7-dimethyl-3H-phenoxazine-3-one against Meth A tumor transplanted into BALB/c mice. Anticancer Drugs 11, 653-657.
62. Tannock, I.F. and Rotin, D. (1989) Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res. 49, 4373-4384.